Coave Therapeutics
Claudia is a scientist and entrepreneur with over 20 years’ research and industry experience. She most recently served as Senior Vice President of Portfolio Strategy at Astellas Pharma in Tokyo, Japan. Prior to this, Claudia co-founded Universal Cells, where she served as CEO until it was acquired by Astellas for over $100 million. Claudia also co-founded Halo-Bio RNAi Therapeutics and served as its Chief Scientific Officer.
This person is not in any offices
Coave Therapeutics
2 followers
Coave Therapeutics develops innovative gene therapy products for rare ophthalmic diseases to preserve visual autonomy in affected patients.